Log In
BCIQ
Print this Print this
 

PLAC Test ELISA Kit

  Manage Alerts
Collapse Summary General Information
Company Diadexus Inc.
DescriptionAutomatic in vitro test measuring lipoprotein-associated phospholipase A2 (Lp-PLA2)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsAssess risk for coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis; To assess the risk for atherosclerosis in patients with two or more cardiovascular risk factors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$1.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/08/2015

Undisclosed

$1.0M

Undisclosed

Get a free BioCentury trial today